-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on GE HealthCare Techs, Raises Price Target to $80

Benzinga·11/03/2026 16:01:40
Diffusion vocale
UBS analyst Graham Doyle maintains GE HealthCare Techs (NASDAQ:GEHC) with a Neutral and raises the price target from $73 to $80.